Discussion on access to Cannabis-derived drugs in the light of Health Innovation in Brazil

Detalhes bibliográficos
Autor(a) principal: Villas Bôas, Glauco de Kruse
Data de Publicação: 2020
Outros Autores: Rezende, Mayara de Azeredo
Tipo de documento: Artigo
Idioma: por
Título da fonte: Revista Fitos
Texto Completo: https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/960
Resumo: The discussion on access to Cannabis-derived drugs, in the light of Health Innovation in Brazil, corresponds to a case study, constructed through narratives frames. The narrative of Health Innovation describes theoretical concepts of an evolutionary aspect of the economy and the elaboration of a National Health Innovation System from the perspective of the Health Industrial Economic Complex. The Research on the Medical Use of Cannabis reveals the contribution of science by opening the path to innovation. The history of Judicialization and Regulation as a means of access to medicines in Brazil, shows that judicial decisions can deter the public health policies implementation budget. It also registers the RDC 327, 2019 publication from Anvisa, providing rules for manufacturing and importing of Cannabis products in Brazil, without solving the access to these drugs. A discussion in a new perspective indicates that Productive Development Partnerships (PDPs) as an alternative to the national production of Cannabis drugs, expanding access to them. This study concludes that new regulatory measures are necessary, in addition to the recognition of Cannabis drugs as strategic for the Unified Health System.
id FIOCRUZ-1_effdc6b1e8adf13331a128273233587b
oai_identifier_str oai:ojs.revistafitos.far.fiocruz.br:article/960
network_acronym_str FIOCRUZ-1
network_name_str Revista Fitos
repository_id_str
spelling Discussion on access to Cannabis-derived drugs in the light of Health Innovation in BrazilDiscussão sobre o acesso aos medicamentos derivados da Cannabis à luz da Inovação em Saúde no BrasilInnovation and HealthAccessCannabis sp. drugsInovação e SaúdeAcessoMedicamentos da CannabisThe discussion on access to Cannabis-derived drugs, in the light of Health Innovation in Brazil, corresponds to a case study, constructed through narratives frames. The narrative of Health Innovation describes theoretical concepts of an evolutionary aspect of the economy and the elaboration of a National Health Innovation System from the perspective of the Health Industrial Economic Complex. The Research on the Medical Use of Cannabis reveals the contribution of science by opening the path to innovation. The history of Judicialization and Regulation as a means of access to medicines in Brazil, shows that judicial decisions can deter the public health policies implementation budget. It also registers the RDC 327, 2019 publication from Anvisa, providing rules for manufacturing and importing of Cannabis products in Brazil, without solving the access to these drugs. A discussion in a new perspective indicates that Productive Development Partnerships (PDPs) as an alternative to the national production of Cannabis drugs, expanding access to them. This study concludes that new regulatory measures are necessary, in addition to the recognition of Cannabis drugs as strategic for the Unified Health System.A discussão sobre o acesso aos medicamentos derivados da Cannabis, à luz da Inovação em Saúde no Brasil se enquadra como um estudo de caso, construído através de molduras narrativas. A narrativa sobre a Inovação em Saúde descreve conceitos teóricos de uma vertente evolucionária da economia e a elaboração de um Sistema Nacional de Inovação em Saúde na perspectiva do Complexo Econômico Industrial da Saúde. A Pesquisa do uso Medicinal da Cannabis revela a contribuição da ciência abrindo caminho para a inovação. Um histórico sobre a Judicialização e Regulação como via de acesso aos medicamentos no Brasil, demonstra que as decisões judiciais podem comprometer o orçamento para a realização das políticas de saúde pública. Registra ainda a publicação, em 2019, da RDC 327 da Anvisa, que dispõe sobre a fabricação e importação de produtos da Cannabis no Brasil, sem resolver o acesso a tais medicamentos. Uma discussão apresentada sob um novo prisma sinaliza as Parcerias de Desenvolvimento Produtivo (PDPs) como uma alternativa para a produção nacional dos medicamentos da Cannabis ampliando o acesso aos mesmos. Este estudo conclui que novas medidas regulatórias serão necessárias, além do reconhecimento dos medicamentos da Cannabis como estratégicos para o Sistema Único de Saúde.Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz2020-08-20info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/htmlhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/96010.32712/2446-4775.2020.960Revista Fitos; Vol. 14 No. 2 (2020); 259-284Revista Fitos; Vol. 14 Núm. 2 (2020); 259-284Revista Fitos; v. 14 n. 2 (2020); 259-2842446-47751808-9569reponame:Revista Fitosinstname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZporhttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/960/674https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/960/675Copyright (c) 2020 Revista Fitoshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessVillas Bôas, Glauco de KruseRezende, Mayara de Azeredo2020-09-30T14:59:12Zoai:ojs.revistafitos.far.fiocruz.br:article/960Revistahttps://revistafitos.far.fiocruz.br/index.php/revista-fitos/PUBhttp://revistafitos.far.fiocruz.br/index.php/revista-fitos/oairevistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br2446-47752446-4775opendoar:2020-09-30T14:59:12Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.none.fl_str_mv Discussion on access to Cannabis-derived drugs in the light of Health Innovation in Brazil
Discussão sobre o acesso aos medicamentos derivados da Cannabis à luz da Inovação em Saúde no Brasil
title Discussion on access to Cannabis-derived drugs in the light of Health Innovation in Brazil
spellingShingle Discussion on access to Cannabis-derived drugs in the light of Health Innovation in Brazil
Villas Bôas, Glauco de Kruse
Innovation and Health
Access
Cannabis sp. drugs
Inovação e Saúde
Acesso
Medicamentos da Cannabis
title_short Discussion on access to Cannabis-derived drugs in the light of Health Innovation in Brazil
title_full Discussion on access to Cannabis-derived drugs in the light of Health Innovation in Brazil
title_fullStr Discussion on access to Cannabis-derived drugs in the light of Health Innovation in Brazil
title_full_unstemmed Discussion on access to Cannabis-derived drugs in the light of Health Innovation in Brazil
title_sort Discussion on access to Cannabis-derived drugs in the light of Health Innovation in Brazil
author Villas Bôas, Glauco de Kruse
author_facet Villas Bôas, Glauco de Kruse
Rezende, Mayara de Azeredo
author_role author
author2 Rezende, Mayara de Azeredo
author2_role author
dc.contributor.author.fl_str_mv Villas Bôas, Glauco de Kruse
Rezende, Mayara de Azeredo
dc.subject.por.fl_str_mv Innovation and Health
Access
Cannabis sp. drugs
Inovação e Saúde
Acesso
Medicamentos da Cannabis
topic Innovation and Health
Access
Cannabis sp. drugs
Inovação e Saúde
Acesso
Medicamentos da Cannabis
description The discussion on access to Cannabis-derived drugs, in the light of Health Innovation in Brazil, corresponds to a case study, constructed through narratives frames. The narrative of Health Innovation describes theoretical concepts of an evolutionary aspect of the economy and the elaboration of a National Health Innovation System from the perspective of the Health Industrial Economic Complex. The Research on the Medical Use of Cannabis reveals the contribution of science by opening the path to innovation. The history of Judicialization and Regulation as a means of access to medicines in Brazil, shows that judicial decisions can deter the public health policies implementation budget. It also registers the RDC 327, 2019 publication from Anvisa, providing rules for manufacturing and importing of Cannabis products in Brazil, without solving the access to these drugs. A discussion in a new perspective indicates that Productive Development Partnerships (PDPs) as an alternative to the national production of Cannabis drugs, expanding access to them. This study concludes that new regulatory measures are necessary, in addition to the recognition of Cannabis drugs as strategic for the Unified Health System.
publishDate 2020
dc.date.none.fl_str_mv 2020-08-20
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/960
10.32712/2446-4775.2020.960
url https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/960
identifier_str_mv 10.32712/2446-4775.2020.960
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/960/674
https://revistafitos.far.fiocruz.br/index.php/revista-fitos/article/view/960/675
dc.rights.driver.fl_str_mv Copyright (c) 2020 Revista Fitos
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2020 Revista Fitos
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/html
dc.publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
publisher.none.fl_str_mv Centro de Inovação em Biodiversidade e Saúde - Farmanguinhos/Fiocruz
dc.source.none.fl_str_mv Revista Fitos; Vol. 14 No. 2 (2020); 259-284
Revista Fitos; Vol. 14 Núm. 2 (2020); 259-284
Revista Fitos; v. 14 n. 2 (2020); 259-284
2446-4775
1808-9569
reponame:Revista Fitos
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Revista Fitos
collection Revista Fitos
repository.name.fl_str_mv Revista Fitos - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv revistafitos@far.fiocruz.br || eugenio.telles@far.fiocruz.br
_version_ 1798313475447980032